294 related articles for article (PubMed ID: 17360188)
1. The concise synthesis of chalcone, indanone and indenone analogues of combretastatin A4.
Kerr DJ; Hamel E; Jung MK; Flynn BL
Bioorg Med Chem; 2007 May; 15(9):3290-8. PubMed ID: 17360188
[TBL] [Abstract][Full Text] [Related]
2. 1,5-Disubstituted 1,2,3-triazoles as cis-restricted analogues of combretastatin A-4: Synthesis, molecular modeling and evaluation as cytotoxic agents and inhibitors of tubulin.
Odlo K; Hentzen J; dit Chabert JF; Ducki S; Gani OA; Sylte I; Skrede M; Flørenes VA; Hansen TV
Bioorg Med Chem; 2008 May; 16(9):4829-38. PubMed ID: 18396050
[TBL] [Abstract][Full Text] [Related]
3. Design, synthesis, and biological evaluation of thiophene analogues of chalcones.
Romagnoli R; Baraldi PG; Carrion MD; Cara CL; Cruz-Lopez O; Preti D; Tolomeo M; Grimaudo S; Di Cristina A; Zonta N; Balzarini J; Brancale A; Sarkar T; Hamel E
Bioorg Med Chem; 2008 May; 16(10):5367-76. PubMed ID: 18440234
[TBL] [Abstract][Full Text] [Related]
4. Synthesis and evaluation of azetidinone analogues of combretastatin A-4 as tubulin targeting agents.
O'Boyle NM; Carr M; Greene LM; Bergin O; Nathwani SM; McCabe T; Lloyd DG; Zisterer DM; Meegan MJ
J Med Chem; 2010 Dec; 53(24):8569-84. PubMed ID: 21080725
[TBL] [Abstract][Full Text] [Related]
5. Novel A-ring and B-ring modified combretastatin A-4 (CA-4) analogues endowed with interesting cytotoxic activity.
Simoni D; Romagnoli R; Baruchello R; Rondanin R; Grisolia G; Eleopra M; Rizzi M; Tolomeo M; Giannini G; Alloatti D; Castorina M; Marcellini M; Pisano C
J Med Chem; 2008 Oct; 51(19):6211-5. PubMed ID: 18783207
[TBL] [Abstract][Full Text] [Related]
6. Lead identification of conformationally restricted β-lactam type combretastatin analogues: synthesis, antiproliferative activity and tubulin targeting effects.
Carr M; Greene LM; Knox AJ; Lloyd DG; Zisterer DM; Meegan MJ
Eur J Med Chem; 2010 Dec; 45(12):5752-66. PubMed ID: 20933304
[TBL] [Abstract][Full Text] [Related]
7. Synthesis, dimerization, and biological activity of hexaoxygenated chalcones related to calythropsin and combretastatins.
Seguin E; Elomri A; Magiatis P; Skaltsounis AL; Chao LR; Tillequin F
Nat Prod Lett; 2002 Jun; 16(3):187-93. PubMed ID: 12049219
[TBL] [Abstract][Full Text] [Related]
8. Synthesis and biological evaluation of vinylogous combretastatin A-4 derivatives.
Kaffy J; Pontikis R; Florent JC; Monneret C
Org Biomol Chem; 2005 Jul; 3(14):2657-60. PubMed ID: 15999202
[TBL] [Abstract][Full Text] [Related]
9. Lead identification of conformationally restricted benzoxepin type combretastatin analogs: synthesis, antiproliferative activity, and tubulin effects.
Barrett I; Carr M; O'Boyle N; Greene LM; Knox AJ; Lloyd DG; Zisterer DM; Meegan MJ
J Enzyme Inhib Med Chem; 2010 Apr; 25(2):180-94. PubMed ID: 20222762
[TBL] [Abstract][Full Text] [Related]
10. Antineoplastic agents. 445. Synthesis and evaluation of structural modifications of (Z)- and (E)-combretastatin A-41.
Pettit GR; Rhodes MR; Herald DL; Hamel E; Schmidt JM; Pettit RK
J Med Chem; 2005 Jun; 48(12):4087-99. PubMed ID: 15943482
[TBL] [Abstract][Full Text] [Related]
11. Isoxazole-type derivatives related to combretastatin A-4, synthesis and biological evaluation.
Kaffy J; Pontikis R; Carrez D; Croisy A; Monneret C; Florent JC
Bioorg Med Chem; 2006 Jun; 14(12):4067-77. PubMed ID: 16510288
[TBL] [Abstract][Full Text] [Related]
12. A concise synthesis of paucifloral F and related indanone analogues via palladium-catalyzed α-arylation.
Yang Y; Philips D; Pan S
J Org Chem; 2011 Mar; 76(6):1902-5. PubMed ID: 21291249
[TBL] [Abstract][Full Text] [Related]
13. Potent antitubulin tumor cell cytotoxins based on 3-aroyl indazoles.
Duan JX; Cai X; Meng F; Lan L; Hart C; Matteucci M
J Med Chem; 2007 Mar; 50(5):1001-6. PubMed ID: 17286393
[TBL] [Abstract][Full Text] [Related]
14. Design, synthesis and biological evaluation of novel chalcone derivatives as antitubulin agents.
Zhang H; Liu JJ; Sun J; Yang XH; Zhao TT; Lu X; Gong HB; Zhu HL
Bioorg Med Chem; 2012 May; 20(10):3212-8. PubMed ID: 22503741
[TBL] [Abstract][Full Text] [Related]
15. Antiproliferative activities of a library of hybrids between indanones and HDAC inhibitor SAHA and MS-275 analogues.
Charrier C; Roche J; Gesson JP; Bertrand P
Bioorg Med Chem Lett; 2007 Nov; 17(22):6142-6. PubMed ID: 17897824
[TBL] [Abstract][Full Text] [Related]
16. Synthesis and anticancer activity of 2-benzylidene indanones through inhibiting tubulin polymerization.
Prakasham AP; Saxena AK; Luqman S; Chanda D; Kaur T; Gupta A; Yadav DK; Chanotiya CS; Shanker K; Khan F; Negi AS
Bioorg Med Chem; 2012 May; 20(9):3049-57. PubMed ID: 22472045
[TBL] [Abstract][Full Text] [Related]
17. Domino approach to 2-aroyltrimethoxyindoles as novel heterocyclic combretastatin A4 analogues.
Arthuis M; Pontikis R; Chabot GG; Quentin L; Scherman D; Florent JC
Eur J Med Chem; 2011 Jan; 46(1):95-100. PubMed ID: 21112130
[TBL] [Abstract][Full Text] [Related]
18. Enantioselective synthesis of substituted indanones from silyloxyallenes.
Brekan JA; Reynolds TE; Scheidt KA
J Am Chem Soc; 2010 Feb; 132(5):1472-3. PubMed ID: 20085317
[TBL] [Abstract][Full Text] [Related]
19. New antitubulin derivatives in the combretastatin A4 series: synthesis and biological evaluation.
Borrel C; Thoret S; Cachet X; Guénard D; Tillequin F; Koch M; Michel S
Bioorg Med Chem; 2005 Jun; 13(11):3853-64. PubMed ID: 15863010
[TBL] [Abstract][Full Text] [Related]
20. Effects of a combretastatin A4 analogous chalcone and its Pt-complex on cancer cells: A comparative study of uptake, cell cycle and damage to cellular compartments.
Zoldakova M; Kornyei Z; Brown A; Biersack B; Madarász E; Schobert R
Biochem Pharmacol; 2010 Nov; 80(10):1487-96. PubMed ID: 20709029
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
